News & Events
Displaying 17 - 31 of 31
Displaying 17 - 31 of 31
UCSF Department of Surgery Faculty Honored with Excellence in Teaching Awards
UCSF Department of Surgery
October 02, 2017
The Haile T. Debas Academy of Medical Educators presented seven Department of Surgery faculty with the Excellence in Teaching Award for 2017 at a ceremony on September 11th at the UCSF School of Nursing, held in conjunction with the Academy's induction of new members. The Academy's Excellence in Teaching Awards...
Inside Surgery Spring/Summer 2017
UCSF Department of Surgery
August 17, 2017
The Spring/Summer 2017 issue of Inside Surgery is now available online. Inside Surgery is a Department of Surgery brochure showcasing the clinical and research advances of our faculty. The edition highlights minimally invasive bariatric surgery t o treat metabolic disease, and robotic surgery deployed across a...
Eric Nakakura and Research Group Awarded $1.2M Grant to Study Small Intestinal Neuroendocrine Tumors
UCSF Surgical Oncology Program
June 03, 2017
Eric Nakakura, M.D., Ph.D. , Associate Professor of Surgery at UCSF and a leading authority on neuroendocrine tumors of the gastrointestinal tract and pancreas, is among a team of researchers awarded $1.2M grant by the Neuroendocrine Tumor Research Foundation (NETRF) to elucidate the causes of small intestinal...
Eric Nakakura and Emily Bergsland Discuss Carcinoid Syndrome Treatment on "Healthy Body, Healthy Mind" Series
UCSF Surgical Oncology Program
January 03, 2017
Eric Nakakura, M.D., Ph.D., a UCSF gastrointestinal cancer surgeon and Emily Bergsland, M.D.. a UCSF gastrointestinal oncologist, recently discussed the treatment of carcinoid syndrome on "Healthy Body, Healthy Mind", a series hosted by Information Television Network (ITV), a PBS content affiliate. Dr. Nakakura is...
Surgery Now a Realistic Option for More Patients with Pancreatic Cancer
UCSF Surgical Oncology Program
September 10, 2016
While researchers race to find improved medical therapies for pancreatic ductal adenocarcinoma (PDAC), surgery remains the most effective treatment. Unfortunately, a large percentage of PDAC patients are not surgical candidates because by the time of diagnosis, the disease has metastasized. Even among those...
Inside Surgery Winter-Spring 2016
UCSF Department of Surgery
April 07, 2016
The Winter-Spring 2016 issue of Inside Surgery focuses on how the new Mission Bay hospitals are enhancing surgical care. New surgical suites, for example, feature advanced technologies and resources that are optimal for patients. The move is also fostering research collaborations as our surgeons work in close...
Carlos Corvera Awarded Maurice Galante, MD Distinguished Professorship in Hepatobiliary Surgery
UCSF Department of Surgery
July 14, 2015
Carlos Corvera M.D. was recently awarded the Maurice Galante, MD Distinguished Professorship in Hepatobiliary Surgery, recognizing his achievements and professional development in general surgery. The Professorship honors the late Maurice Galante, M.D., UCSF professor emeritus of surgery. Dr. Galante was described...
Study Shows Excellent Post-Transplant Outcomes Following Down-Staging of HCC Patients
UCSF Transplant Surgery
December 10, 2014
Successful downstaging of selected patients with HCC (hepatocellular carcinoma) before liver transplantation leads to excellent 5-year recurrence-free and overall survival rates post-transplant, according to a just-reported multicenter study led by UCSF Transplant Program investigators. Medscape Medical News...
CFCF Awards New Research Grant to Dr. Eric Nakakura to Study Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors
UCSF Surgical Oncology Program
December 13, 2012
Eric Nakakura, M.D., Ph.D. has been awarded the 2012 Caring for Carcinoid Foundation-AACR Grant for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research. Dr. Nakakura will receive $250,000 over two years to understand why some patients develop resistance to mTOR inhibiting drugs like everolimus. In...
Deadly Liver Cancer May Be Triggered by Cells Changing Identity, UCSF Study Shows
Willenbring Lab
July 16, 2012
Intrahepatic bile duct cancer, a rare and deadly form of cancer, known formally as cholangiocarcinoma, has been assumed to derive from cells in the bile ducts of the liver. However, a n international team, led by Holger F. Willenbring, M.D., Ph.D., Associate Professor of Developmental and Stem Cell Biology in the...
Hepatobiliary & Pancreas Service at UCSF
UCSF Department of Surgery
June 01, 2012
In July 2011, the Department of Surgery created a new Hepatobiliary and Pancreas Service naming Carlos Corvera M.D., a hepatobiliary surgical oncologist, as its Chief. The multidisciplinary program brings together faculty members from surgery, hepatology, medical oncology, anesthesia, radiology and pathology to...
Serendipitous Discovery of a Cancer Starter
UCSF Surgical Oncology Program
December 08, 2010
Then post-graduate student Eric Nakakura, M.D., Ph.D., working in the lab of Johns' Hopkins cancer biologist Barry Nelkin, was struck by how the migration of neurological cells to form the developing brain bore an uncanny similarly to the inexorable migration of invasive cells to distant sites in cancer metastasis...
Concert to Benefit the GI Oncology Research Program
UCSF Surgical Oncology Program
May 05, 2010
Felsen, a classic and Indie rock band founded by drummer Andrew Griffin, Luce, Jesse Brewster and Brad Brooks held a benefit concert on Thursday, July 15th at 8 p.m at San Francisco's Red Devil Lounge. Proceeds from this exciting evening of music and dancing supported the research of the UCSF GI Oncology Research...
UCSF Scientists Illuminate How microRNAs Drive Tumor Progression
UCSF Surgical Oncology Program
September 16, 2009
UCSF researchers, led by Doug Hanahan, Ph.D., have identified collections of tiny molecules known as microRNAs that affect distinct processes critical for cancer progression. The findings help elucidate the important regulatory function of microRNAs in tumor biology. Eric Nakakura, M.D., Ph.D. (pictured), a...
Surgical & Therapeutic Advances in Pancreatic Cancer
UCSF Surgical Oncology Program
July 15, 2009
For now, the only possible route to outliving pancreas cancer is complete removal of the tumor via surgery. Surgery for pancreas cancer is long and demanding, and surgeons must be practiced to consistently perform it well. Pancreas cancer surgery outcomes are better at high-volume, major medical centers such as...